The National Institute of Health and Care Excellence (NICE) – the drugs advisory body to the National Health Service (NHS) in the UK – has criticized Roche Holding Ltd. (ADR) (RHHBY) over its refusal to cut prices for Kadcyla, which is used to treat severe cases of breast cancer. Kadcyla is approved to treat HER2-positive breast cancer that has spread to other parts of the … Continue reading Hot Alert : ImmunoGen (NASDAQ:IMGN), Walt Disney Company (NYSE:DIS), Shanda Games Limited (NASDAQ:GAME), EQT Midstream Partners, LP (NYSE:EQM), Northeast Bancorp (NASDAQ:NBN)